From Genomes to Neurons: Jorge Radlowski Nova and the AI Revolution in Neuroscience

Young talent and technological innovation are the engine driving Scorrochano Lab! Today we celebrate a thrilling milestone: the first anniversary of Jorge Radlowski Nova as a predoctoral researcher on our team. Bringing together computational brilliance and biomedical vision, Jorge is leading the charge in applying Artificial Intelligence and advanced genomics to unravel the complexities of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

The Fusion of Artificial Intelligence and Human Genomics

At Scorrochano Lab, Jorge’s doctoral research illustrates the immense power of bridging computer science and molecular neurology. His core mission is to transform billions of biological data points into predictive diagnostic tools.

Jorge develops genomic AI systems based on foundational deep learning models. Much like large language models comprehend human grammar and literature, genomic foundation models learn the intricate, multi-layered syntax of human DNA and RNA. Applied to neurodegenerative disorders, these models identify subtle, non-linear genetic interactions that traditional statistical methods miss, shedding light on why specific individuals develop ALS or FTD.

Moreover, Jorge is building a multimodal data integration architecture. Rather than inspecting genomics in isolation, his framework harmonizes clinical patient registries, longitudinal blood and CSF biomarkers, and comprehensive transcriptomic datasets. This generates unified, 360-degree patient representations capable of stratifying disease subphenotypes, predicting progression rates, and spotlighting actionable therapeutic targets.

A vital piece of this pipeline utilizes Oxford Nanopore long-read sequencing technology. By analyzing extensive contiguous strands of DNA and RNA, Jorge’s reproducible bioinformatic pipelines unmask structural variants and complex splicing events that conventional short-read sequencing simply cannot capture.

Why This Work is Essential: Toward True Precision Medicine

Neurodegenerative disorders currently suffer from late diagnostic delays and considerable prognostic uncertainty. Jorge’s computational framework directly addresses these bottlenecks by enabling:
– Earlier and More Accurate Diagnosis: Detecting subtle molecular and phenotypic warning signs before irreversible motor neuron loss occurs.
– Personalized Therapeutic Strategies: Tailoring clinical approaches to the specific genomic and biomarker profile of each patient.
– Discovery of Novel Drug Targets: Identifying previously hidden regulatory networks that govern disease progression.

Interdisciplinary Minds Shaping Tomorrow’s Science

With a background in Biotechnology from UFV and a Master’s in Computational Biology from UPM, Jorge exemplifies the multidisciplinary scientist of the future. His intellectual appetite, humor, and curiosity make him a cornerstone of our lab. Happy first anniversary, Jorge—here is to many more breakthroughs!